Site-specific Immunosuppression in Vascularized Composite Allotransplantation: Prospects and Potential

Overview

Journal Clin Dev Immunol

Specialty Allergy & Immunology

Date 2013 Mar 12

PMID 23476677

Citations 16

Authors

Jonas T Schnider

Matthias Weinstock

Jan A Plock

Mario G Solari

Raman Venkataramanan

Xin Xiao Zheng

Vijay S Gorantla

Affiliations

Soon will be listed here.

Abstract

Skin is the most immunogenic component of a vascularized composite allograft (VCA) and is the primary trigger and target of rejection. The skin is directly accessible for visual monitoring of acute rejection (AR) and for directed biopsy, timely therapeutic intervention, and management of AR. Logically, antirejection drugs, biologics, or other agents delivered locally to the VCA may reduce the need for systemic immunosuppression with its adverse effects. Topical FK 506 (tacrolimus) and steroids have been used in clinical VCA as an adjunct to systemic therapy with unclear beneficial effects. However, there are no commercially available topical formulations for other widely used systemic immunosuppressive drugs such as mycophenolic acid, sirolimus, and everolimus. Investigating the site-specific therapeutic effects and efficacy of systemically active agents may enable optimizing the dosing, frequency, and duration of overall immunosuppression in VCA with minimization or elimination of long-term drug-related toxicity.

Citing Articles

Retinal transplant immunology and advancements.

Perez V, Mousa H, Miyagishima K, Reed A, Su A, Greenwell T Stem Cell Reports. 2024; 19(6):817-829.

PMID: 38729155 PMC: 11297553. DOI: 10.1016/j.stemcr.2024.04.007.

Nerve Wrap for Local Delivery of FK506/Tacrolimus Accelerates Nerve Regeneration.

Xiao B, Feturi F, Su A, Van der Merwe Y, Barnett J, Jabbari K Int J Mol Sci. 2024; 25(2).

PMID: 38255920 PMC: 10815243. DOI: 10.3390/ijms25020847.

A Reversibly Thermoresponsive, Theranostic Nanoemulgel for Tacrolimus Delivery to Activated Macrophages: Formulation and In Vitro Validation.

Vichare R, Crelli C, Liu L, Das A, McCallin R, Zor F Pharmaceutics. 2023; 15(10).

PMID: 37896130 PMC: 10610217. DOI: 10.3390/pharmaceutics15102372.

Tacrolimus-Eluting Disk within the Allograft Enables Vascularized Composite Allograft Survival with Site-Specific Immunosuppression without Systemic Toxicity.

Feturi F, Unadkat J, Zhang W, Hag M, Wang Y, Komatsu C Pharm Res. 2022; 39(9):2179-2190.

PMID: 35915321 DOI: 10.1007/s11095-022-03345-4.

The Positive Impact of Donor Bone Marrow Cells Transplantation into Immunoprivileged Compartments on the Survival of Vascularized Skin Allografts.

Jundzill A, Klimczak A, Sonmez E, Brzezicki G, Siemionow M Arch Immunol Ther Exp (Warsz). 2021; 69(1):28.

PMID: 34633538 PMC: 8505373. DOI: 10.1007/s00005-021-00631-8.

References

McCaughey C, Machan M, Bennett R, Zone J, Hull C . Pimecrolimus 1% cream for oral erosive lichen planus: a 6-week randomized, double-blind, vehicle-controlled study with a 6-week open-label extension to assess efficacy and safety. J Eur Acad Dermatol Venereol. 2010; 25(9):1061-7. DOI: 10.1111/j.1468-3083.2010.03923.x. View

Cendales L, Kirk A, Moresi J, Ruiz P, Kleiner D . Composite tissue allotransplantation: classification of clinical acute skin rejection. Transplantation. 2006; 81(3):418-22. DOI: 10.1097/01.tp.0000185304.49987.d8. View

Soria A, Agbo-Godeau S, Taieb A, Frances C . Treatment of refractory oral erosive lichen planus with topical rapamycin: 7 cases. Dermatology. 2008; 218(1):22-5. DOI: 10.1159/000172830. View

Williams A, Barry B . Penetration enhancers. Adv Drug Deliv Rev. 2004; 56(5):603-18. DOI: 10.1016/j.addr.2003.10.025. View

Schneeberger S, Lucchina S, Lanzetta M, Brandacher G, Bosmuller C, Steurer W . Cytomegalovirus-related complications in human hand transplantation. Transplantation. 2005; 80(4):441-7. DOI: 10.1097/01.tp.0000168454.68139.0a. View

Gruber S, Hrushesky W, Cipolle R, Erdmann G, Burke B, Skjei K . Local immunosuppression with reduced systemic toxicity in a canine renal allograft model. Transplantation. 1989; 48(6):936-43. DOI: 10.1097/00007890-198912000-00008. View

Furtado A, Perdigoto R, Oliveira F, Geraldes B, Furtado E, Tome L . Local immunosuppression in clinical small bowel transplantation (report of two cases). Transplant Proc. 2000; 32(6):1206-8. DOI: 10.1016/s0041-1345(00)01187-8. View

Schon M, Krahn T, Schon M, Antonicek H, Schultz J, Ludwig R . Efomycine M, a new specific inhibitor of selectin, impairs leukocyte adhesion and alleviates cutaneous inflammation. Nat Med. 2002; 8(4):366-72. DOI: 10.1038/nm0402-366. View

Ang-Tiu C, Meghrajani C, Maano C . Pimecrolimus 1% cream for the treatment of seborrheic dermatitis: a systematic review of randomized controlled trials. Expert Rev Clin Pharmacol. 2011; 5(1):91-7. DOI: 10.1586/ecp.11.68. View

10.

Iacono A, Smaldone G, Keenan R, Diot P, Dauber J, Zeevi A . Dose-related reversal of acute lung rejection by aerosolized cyclosporine. Am J Respir Crit Care Med. 1997; 155(5):1690-8. DOI: 10.1164/ajrccm.155.5.9154878. View

11.

Wang X, Alfrey E, Posselt A, Tafra L, Alak A, Dafoe D . Intraportal delivery of immunosuppression to intrahepatic islet allograft recipients. Transpl Int. 1995; 8(4):268-72. DOI: 10.1007/BF00346879. View

12.

Prausnitz M, Langer R . Transdermal drug delivery. Nat Biotechnol. 2008; 26(11):1261-8. PMC: 2700785. DOI: 10.1038/nbt.1504. View

13.

Iacono A, Johnson B, Grgurich W, Youssef J, Corcoran T, Seiler D . A randomized trial of inhaled cyclosporine in lung-transplant recipients. N Engl J Med. 2006; 354(2):141-50. DOI: 10.1056/NEJMoa043204. View

14.

Banchereau J, Steinman R . Dendritic cells and the control of immunity. Nature. 1998; 392(6673):245-52. DOI: 10.1038/32588. View

15.

Morelon E, Kanitakis J, Petruzzo P . Immunological issues in clinical composite tissue allotransplantation: where do we stand today?. Transplantation. 2012; 93(9):855-9. DOI: 10.1097/TP.0b013e31824728b8. View

16.

Lee W, Yaremchuk M, Pan Y, Randolph M, Tan C, Weiland A . Relative antigenicity of components of a vascularized limb allograft. Plast Reconstr Surg. 1991; 87(3):401-11. DOI: 10.1097/00006534-199103000-00001. View

17.

Lanzetta M, Petruzzo P, Margreiter R, Dubernard J, Schuind F, Breidenbach W . The International Registry on Hand and Composite Tissue Transplantation. Transplantation. 2005; 79(9):1210-4. DOI: 10.1097/01.tp.0000157118.28394.fa. View

18.

Shirbacheh M, Jones J, Breidenbach W, McCabe S, Barker J, Gruber S . The case for local immunosuppression in composite tissue allotransplantation. Transplant Proc. 1998; 30(6):2739-42. DOI: 10.1016/s0041-1345(98)00800-8. View

19.

Caproni M, Torchia D, Schincaglia E, Volpi W, Frezzolini A, Schena D . Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis. Br J Dermatol. 2006; 155(4):722-8. DOI: 10.1111/j.1365-2133.2006.07398.x. View

20.

Lebwohl M, Freeman A, Shane Chapman M, Feldman S, Hartle J, Henning A . Tacrolimus ointment is effective for facial and intertriginous psoriasis. J Am Acad Dermatol. 2004; 51(5):723-30. DOI: 10.1016/j.jaad.2004.07.011. View